Related Experiment Videos
[Protocols on thrombosis and hemostasis in clinical practice]
Acta Medica Portuguesa
|January 1, 1994
Summary
This study outlines essential protocols for managing thrombosis, including pre-operative testing, deep vein thrombosis (DVT) prophylaxis and treatment with low-molecular-weight heparin (LMWH), and arterial thrombosis prevention. It also covers anticoagulant supervision and thrombosis prophylaxis in specific deficiencies during pregnancy.
Area of Science:
- Hematology
- Vascular Medicine
- Pharmacology
Context:
- Thrombosis presents a significant clinical challenge, necessitating standardized management protocols.
- Effective prophylaxis and treatment are crucial for preventing serious complications like deep vein thrombosis (DVT) and arterial thrombosis.
Purpose:
- To establish comprehensive protocols for the analytic and therapeutic management of thrombotic disorders.
- To outline guidelines for the use of low-molecular-weight heparin (LMWH) in DVT prophylaxis and treatment.
- To provide recommendations for antiplatelet therapy in arterial thrombosis prevention and thrombosis management in specific genetic deficiencies, including during pregnancy.
Summary:
- Protocols cover pre-operative and pre-thrombotic state analytic testing.
- Guidelines detail the use of LMWH for DVT prophylaxis and treatment.
- Recommendations include oral anticoagulant supervision, antiplatelet drug use for arterial thrombosis prevention, and prophylaxis for ATIII, Protein C, and Protein S deficiencies, particularly in pregnancy.
Impact:
- Standardized protocols can improve patient outcomes and reduce thrombotic event incidence.
- Consistent application of LMWH and antiplatelet therapies can enhance thrombosis management.
- Addressing thrombosis in specific deficiencies and pregnancy ensures tailored patient care.